The Australian Centre of Excellence in Melanoma Imaging & Diagnosis (ACEMID) recently received an additional $3 million grant from the Medical Research Future Fund. The grant will go towards increasing the accessibility of skin screenings in rural areas of Australia. This includes the establishment of a 16^th site, Mildura Base Public Hospital, where Canfield Scientific’s VECTRA^® WB360 whole-body imaging system will be installed.

This expansion is part of ACEMID’s initiative to address health disparities in regional and rural Australia through the world’s largest melanoma cohort study. Previously, the WB360 system was installed at 15 ACEMID sites in New South Wales, Queensland, and Victoria.

The innovative VECTRA WB360 employs both cross-polarized and non-polarized lighting to generate incredibly detailed 3D images of the entire body in a single capture. Powered by Canfield's state-of-the-art DermaGraphix^® software, these images are pivotal in the surveillance of pigmented lesions. The VECTRA WB360 at each site is being used in ongoing research to determine how artificial intelligence can support dermatologists in developing effective preventative strategies and gaining a deeper understanding of the factors contributing to skin cancer. 

To learn more about the project, click here.

To learn more about VECTRA^® WB360, click here.